Urology · Merrillville, IN
NPI
1376688820
Since 2007
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
400 W 84th Dr
Merrillville, IN, 46410
Phone (219) 736-1255
Groups this clinician bills Medicare through
Medicare paid, 2024
$219K
6,901 services
Medicare patients, 2024
1,390
Average age 76
Drug cost, 2024
$370K
5,577 prescriptions
Company payments, 2025
$582
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian R Billmeyer was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,209 times for 1,034 patients. In total Brian R Billmeyer billed 6,901 services in 65 codes, and Medicare paid $219K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,209 | 1,034 | $10.74 | $13K |
| 81003 Clinical Chemistry | Office | 986 | 844 | $2.19 | $2,162 |
| 99213 Office E&M - Established | Office | 615 | 550 | $57.52 | $35K |
| 99214 Office E&M - Established | Office | 474 | 454 | $79.71 | $38K |
| 99203 Office E&M - New | Office | 249 | 249 | $71.00 | $18K |
| 52000 Cystourethroscopy | Office | 184 | 164 | $159.52 | $29K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 124 | 30 | $0.36 | $44.57 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 102 | 11 | $141.66 | $14K |
| 99222 Hospital E&M - Initial | Facility | 92 | 90 | $92.77 | $8,535 |
| 99232 Hospital E&M - Subsequent | Facility | 70 | 54 | $53.24 | $3,727 |
| 51798 Ultrasound - Nonspecific | Office | 65 | 59 | $7.31 | $475 |
| 99231 Hospital E&M - Subsequent | Facility | 50 | 44 | $34.68 | $1,734 |
| 74420 Standard X-ray | Facility | 42 | 30 | $17.30 | $726 |
| 52332 Cystourethroscopy | Facility | 40 | 29 | $108.45 | $4,338 |
| 99211 Office E&M - Established | Office | 35 | 28 | $16.10 | $563 |
By year: 2022 $224K for 5,681 services; 2023 $203K for 5,638 services; 2024 $219K for 6,901 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 986 | 844 | $2.19 | $2,162 |
| 81001 Clinical Chemistry | 24 | 21 | $2.74 | $65.77 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian R Billmeyer prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,891 prescriptions and refills. In total Brian R Billmeyer wrote 5,577 Medicare prescriptions that cost $370K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,891 | 4,997 | 551 | $25K |
| Finasteride Generic | 1,259 | 3,587 | 383 | $16K |
| Solifenacin Succinate Generic | 403 | 905 | 120 | $40K |
| Cephalexin Generic | 313 | 518 | 102 | $2,336 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 266 | 274 | 205 | $1,997 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 186 | 485 | 51 | $3,202 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 165 | 371 | 53 | $4,843 |
| Myrbetriq Mirabegron | 147 | 313 | 47 | $139K |
| Trimethoprim Generic | 86 | 161 | 28 | $2,985 |
| Estradiol Generic | 82 | 227 | 64 | $4,486 |
| Gemtesa Vibegron | 72 | 106 | 18 | $50K |
| Dutasteride Generic | 60 | 144 | 18 | $1,662 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 52 | 95 | 15 | $3,095 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 48 | 48 | 42 | $277 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 45 | 41 | $145 |
Brand drugs: 411 claims; generic drugs: 5,166 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian R Billmeyer $582 ($582 in general payments such as food, travel and fees) from 12 companies. The largest payer was Janssen Biotech, Inc. with $114.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $114 |
| Urogen Pharma, Inc. URGN | 3 | $113 |
| Abbvie Inc. ABBV | 2 | $59.1 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $51.69 |
| Calyxo, Inc. | 3 | $50.84 |
| Olympus America Inc. | 1 | $41.16 |
| Myriad Genetic Laboratories, Inc. MYGN | 2 | $35 |
| 180 Medical, Inc. | 1 | $29.67 |
| Progenics Pharmaceuticals, Inc. | 1 | $27.91 |
| Coloplast Corp | 1 | $25.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.